Agomab Therapeutics NV (AGMB)

$15.61 +0.96 (6.55%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -46.27M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 617,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule inhibitor of ALK5 or TGFßR1 for the treatment of id...

Industry: Biotechnology
Sector: Healthcare
Phone: 32 3 318 91 70
Address:
Posthoflei 1/6, Antwerp, Belgium
Woodyp123
Woodyp123 Jul. 1 at 3:29 AM
$AGMB why did this just give up all its gains from yesterday
0 · Reply
EddieHayes
EddieHayes Jun. 30 at 1:58 PM
Yesterday’s 52-week high breakouts $UPC +311.49% $NNBR +31.16% $AGMB +29.04% $OUST +28.68% $IRDM +25.44% FCEL +24.70% FCEL +24.17% CCXI +18.33% Key driver: UPC surged after announcing a $10.75M acquisition of Best Praise International, gaining a patent portfolio tied to age-related diseases, neurodegeneration, and drug delivery tech. Takeaway: This is classic momentum + catalyst flow. Low float names can move violently when narrative + volume align. I keep sharing these setups as a hobby. I’m not financially dependent on it, so I prefer to share it free.
0 · Reply
vcaelum
vcaelum Jun. 29 at 8:01 PM
$AGMB in 18 HARD SL 15
0 · Reply
Cache_Money
Cache_Money Jun. 28 at 5:29 PM
$AGMB How are people feeling about gut-restricted ALK5i?
0 · Reply
LewisDaKat
LewisDaKat Jun. 22 at 8:30 PM
$AGMB Buy Recommendation Issued On AGMB By H.C. Wainwright https://marketwirenews.com/stock/agmb/news/buy-recommendation-issued-on-agmb-by-h-c-wainwright-7089203141966569.html?utm_source=stocktwits
0 · Reply
topstockalerts
topstockalerts Jun. 18 at 10:59 PM
$AGMB this advance feels both calm and determined.
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 9 at 1:38 PM
$AGMB closed an easy short here
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 8 at 8:10 PM
$AGMB any buyers here? low vol price movement
0 · Reply
stockexchange01
stockexchange01 Jun. 8 at 5:50 PM
$AGMB 🖕🏿
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 8 at 5:46 PM
$AGMB
0 · Reply
Latest News on AGMB
Agomab Therapeutics NV trading resumes

2026-06-29T20:00:09.000Z - 5 days ago

Agomab Therapeutics NV trading resumes

Agomab Therapeutics NV trading halted, volatility trading pause

2026-06-29T19:56:01.000Z - 5 days ago

Agomab Therapeutics NV trading halted, volatility trading pause

Agomab announces NOV-ERA study design

2026-06-23T20:18:46.000Z - 11 days ago

Agomab announces NOV-ERA study design

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease

Jun 23, 2026, 4:05 PM EDT - 11 days ago

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease

Agomab initiated with a Buy at H.C. Wainwright

2026-06-22T10:05:38.000Z - 12 days ago

Agomab initiated with a Buy at H.C. Wainwright

Agomab Announces Results of Annual General Meeting

May 27, 2026, 5:00 AM EDT - 5 weeks ago

Agomab Announces Results of Annual General Meeting

Agomab to Participate in Upcoming Conferences

May 14, 2026, 7:30 AM EDT - 7 weeks ago

Agomab to Participate in Upcoming Conferences

Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook

Apr 23, 2026, 6:14 PM EDT - 2 months ago

Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook

AgomAb Therapeutics NV Earnings release: Q4 2025

Apr 23, 2026, 7:00 AM EDT - 2 months ago

AgomAb Therapeutics NV Earnings release: Q4 2025

AgomAb Therapeutics NV Annual report: Q4 2025

Apr 23, 2026, 7:00 AM EDT - 2 months ago

AgomAb Therapeutics NV Annual report: Q4 2025

Agomab receives U.S. patent for AGMB-447

2026-03-26T11:31:39.000Z - 3 months ago

Agomab receives U.S. patent for AGMB-447

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Mar 26, 2026, 7:00 AM EDT - 3 months ago

Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis

Agomab initiated with an Outperform at Leerink

2026-03-03T11:47:51.000Z - 4 months ago

Agomab initiated with an Outperform at Leerink

Agomab initiated with an Overweight at Morgan Stanley

2026-03-03T10:06:01.000Z - 4 months ago

Agomab initiated with an Overweight at Morgan Stanley

Agomab initiated with an Overweight at JPMorgan

2026-03-03T10:05:11.000Z - 4 months ago

Agomab initiated with an Overweight at JPMorgan

Agomab Announces Closing of Initial Public Offering

Feb 9, 2026, 4:05 PM EST - 5 months ago

Agomab Announces Closing of Initial Public Offering

Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut

Feb 6, 2026, 12:48 PM EST - 5 months ago

Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut

Agomab opens at $14.70, IPO priced at $16.00

2026-02-06T17:40:13.000Z - 5 months ago

Agomab opens at $14.70, IPO priced at $16.00

Agomab indicated to open at $15.50, IPO priced at $16

2026-02-06T15:55:19.000Z - 5 months ago

Agomab indicated to open at $15.50, IPO priced at $16

Agomab Announces Pricing of Initial Public Offering

Feb 5, 2026, 7:24 PM EST - 5 months ago

Agomab Announces Pricing of Initial Public Offering

AgomAb Therapeutics NV Registration statement: Registration Filing

Jan 29, 2026, 7:00 AM EST - 5 months ago

AgomAb Therapeutics NV Registration statement: Registration Filing

Agomab Therapeutics files for US IPO

Jan 16, 2026, 4:43 PM EST - 6 months ago

Agomab Therapeutics files for US IPO

AgomAb Therapeutics IPO Registration Document (F-1)

Jan 16, 2026, 4:19 PM EST - 6 months ago

AgomAb Therapeutics IPO Registration Document (F-1)

Woodyp123
Woodyp123 Jul. 1 at 3:29 AM
$AGMB why did this just give up all its gains from yesterday
0 · Reply
EddieHayes
EddieHayes Jun. 30 at 1:58 PM
Yesterday’s 52-week high breakouts $UPC +311.49% $NNBR +31.16% $AGMB +29.04% $OUST +28.68% $IRDM +25.44% FCEL +24.70% FCEL +24.17% CCXI +18.33% Key driver: UPC surged after announcing a $10.75M acquisition of Best Praise International, gaining a patent portfolio tied to age-related diseases, neurodegeneration, and drug delivery tech. Takeaway: This is classic momentum + catalyst flow. Low float names can move violently when narrative + volume align. I keep sharing these setups as a hobby. I’m not financially dependent on it, so I prefer to share it free.
0 · Reply
vcaelum
vcaelum Jun. 29 at 8:01 PM
$AGMB in 18 HARD SL 15
0 · Reply
Cache_Money
Cache_Money Jun. 28 at 5:29 PM
$AGMB How are people feeling about gut-restricted ALK5i?
0 · Reply
LewisDaKat
LewisDaKat Jun. 22 at 8:30 PM
$AGMB Buy Recommendation Issued On AGMB By H.C. Wainwright https://marketwirenews.com/stock/agmb/news/buy-recommendation-issued-on-agmb-by-h-c-wainwright-7089203141966569.html?utm_source=stocktwits
0 · Reply
topstockalerts
topstockalerts Jun. 18 at 10:59 PM
$AGMB this advance feels both calm and determined.
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 9 at 1:38 PM
$AGMB closed an easy short here
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 8 at 8:10 PM
$AGMB any buyers here? low vol price movement
0 · Reply
stockexchange01
stockexchange01 Jun. 8 at 5:50 PM
$AGMB 🖕🏿
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 8 at 5:46 PM
$AGMB
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 3 at 7:31 AM
$AGMB
0 · Reply
stockexchange01
stockexchange01 Mar. 30 at 6:11 PM
$AGMB Down nearly 50% since IPO. Yikes! Anything in the works?
0 · Reply
ZdP2
ZdP2 Mar. 30 at 3:15 PM
$AGMB Already down 5$ since I said this last month.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Mar. 26 at 12:45 PM
$VRTX $TVRD $MBOT ONLY 66 WATCHERS IPO RECEIVED U.S PATENT FOR FIBROSIS AN HOUR AGO. GET IN EARLY ----------> $AGMB
1 · Reply
stockexchange01
stockexchange01 Mar. 4 at 8:32 PM
$AGMB 🖕🏿
1 · Reply
stockexchange01
stockexchange01 Feb. 18 at 3:41 PM
$AGMB POS
0 · Reply
ZdP2
ZdP2 Feb. 13 at 12:50 PM
$AGMB Below 5$ soon.
0 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Feb. 12 at 5:24 AM
$AGMB @XPresso here’s an idea … do it yourself ?! JFC
0 · Reply
XPresso
XPresso Feb. 11 at 9:20 PM
$AGMB Does someone has some proper DD?
0 · Reply